Evaluation of the activity and safety of CS 21 barrier genital gel ® compared to topical aciclovir and placebo in symptoms of genital herpes recurrences: a randomized clinical trial
Khemis, A., Duteil, L., Tillet, Y., Dereure, O., Ortonne, J-P.Volume:
28
Language:
english
Journal:
Journal of the European Academy of Dermatology and Venereology
DOI:
10.1111/jdv.12228
Date:
September, 2014
File:
PDF, 318 KB
english, 2014